Bausch Health Companies (BHC) Receivables (2009 - 2026)

Bausch Health Companies has disclosed Receivables across 18 years of filings, most recently posting $2.2 billion for Q1 2026.

• Receivables for Q1 2026 came in at $2.2 billion, up 5.74% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.2 billion (up 5.74% YoY), and the FY2025 annual result was $197.0 million, up 36.81% from the prior year.
• Receivables came in at $2.2 billion for Q1 2026 at Bausch Health Companies, down from $2.4 billion in the prior quarter.
• In the past five years, Receivables ranged from a high of $2.4 billion in Q3 2025 to a low of $144.0 million in Q4 2024.
• The 5-year median for Receivables is $2.0 billion (2023), against an average of $1.9 billion.
• Across the five-year window, Receivables sank 92.79% in 2024 and surged 1532.64% in 2025, its largest moves.
• Bausch Health Companies' Receivables stood at $1.8 billion in 2022, then gained by 11.62% to $2.0 billion in 2023, then tumbled by 92.79% to $144.0 million in 2024, then soared by 1532.64% to $2.4 billion in 2025, then decreased by 6.81% to $2.2 billion in 2026.
• The last three Receivables figures came in at $2.2 billion (Q1 2026), $2.4 billion (Q4 2025), and $2.4 billion (Q3 2025), per Business Quant data.